GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mydecine Innovations Group Inc (NEOE:MYCO) » Definitions » Total Long-Term Liabilities

Mydecine Innovations Group (NEOE:MYCO) Total Long-Term Liabilities : C$5.42 Mil (As of Sep. 2023)


View and export this data going back to 2014. Start your Free Trial

What is Mydecine Innovations Group Total Long-Term Liabilities?

Total Long-Term Liabilities includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities. Mydecine Innovations Group's Total Long-Term Liabilities for the quarter that ended in Sep. 2023 was C$5.42 Mil.

Mydecine Innovations Group Total Long-Term Liabilities Historical Data

The historical data trend for Mydecine Innovations Group's Total Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mydecine Innovations Group Total Long-Term Liabilities Chart

Mydecine Innovations Group Annual Data
Trend Dec13 Aug14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Total Long-Term Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 0.02 0.17 4.42 4.70

Mydecine Innovations Group Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Total Long-Term Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.41 4.70 4.93 5.17 5.42

Mydecine Innovations Group Total Long-Term Liabilities Calculation

Total Long-Term Liabilities represents the obiligation that incurred as part of normal operations that is expected to be repaid beyond the following twelve months or one business cycle, excluding minority interest. It includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities.

Mydecine Innovations Group Total Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Mydecine Innovations Group's Total Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Mydecine Innovations Group (NEOE:MYCO) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mydecine Innovations Group Inc (NEOE:MYCO) » Definitions » Total Long-Term Liabilities
Comparable Companies
XCNQ:CLC XCNQ:RAMM TSXV:VM XCNQ:CPTR TSX:DN TSXV:LFST TSXV:DHB XCNQ:TGIF TSXV:ENTG XCNQ:LOBE ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
MYCOF:USA 0NF0:Germany MYCO:Canada
Address
789 West Pender Street, Suite 810, Vancouver, BC, CAN, V6C 1H2
Website
https://www.mydecine.com
Mydecine Innovations Group Inc is a biopharma and life sciences company engaged in the research, drug development, and clinical trials of psilocybin products.

Mydecine Innovations Group (NEOE:MYCO) Headlines

No Headlines